Head and neck cancers represent a biologically heterogeneous group of malignancies requiring accurate diagnosis, staging, and risk stratification for ...

Drug resistance remains a central barrier to durable responses across cancer therapies, spanning targeted agents, cytotoxic chemotherapy, endocrine ...

In a future perhaps not too far away, artificial intelligence and its subfield of machine learning (ML) tools and models, ...

Researchers have developed a new tool to help clinicians tailor personalized treatment plans for patients with a rare blood ...

AI models can generate more complete summaries of complex cancer pathology reports than physicians, according to a new ...